Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.39 |
| ▸ | CCNA2 | P20248 | 8/20 | 0.36 |
| ▸ | CDK2 | P24941 | 8/20 | 0.36 |
| ▸ | CCNA1 | P78396 | 8/20 | 0.36 |
| ▸ | MKNK1 | Q9BUB5 | 2/20 | 0.35 |
| ▸ | MKNK2 | Q9HBH9 | 2/20 | 0.35 |
| ▸ | DRD4 | P21917 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.34 |
| ▸ | DRD2 | P14416 | 1/20 | 0.34 |
| ▸ | DRD3 | P35462 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2877982 | 0.77 | CDK2 (0.42) | HCAR2CCNA2CDK2CCNA1TDP1 | |
| SCHEMBL2878902 | 0.76 | MEN1 (0.43) | HCAR2MKNK1MKNK2DRD4MEN1 | |
| SCHEMBL17948808 | 0.65 | CCNA2 (0.60) | HCAR2CCNA2CDK2CCNA1MKNK1 | |
| SCHEMBL2374222 | 0.63 | DRD4 (0.67) | HCAR2MKNK1MKNK2DRD4MEN1 | |
| SCHEMBL4469748 | 0.61 | HCAR2 (0.50) | HCAR2CCNA2CDK2CCNA1MKNK1 | |
| SCHEMBL21200998 | 0.61 | CBLB (0.43) | HCAR2KMT2A | |
| SCHEMBL71054 | 0.60 | DRD4 (0.52) | CCNA2CDK2CCNA1MKNK1MKNK2 | |
| SCHEMBL3346932 | 0.60 | USP30 (0.47) | HCAR2CCNA2CDK2CCNA1MKNK1 | |
| SCHEMBL28032854 | 0.60 | HCAR2 (0.40) | HCAR2CCNA2CDK2CCNA1MKNK1 | |
| SCHEMBL90978 | 0.60 | DRD4 (0.48) | CCNA2CDK2CCNA1MKNK1MKNK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1953163-A1 | Pteridinone derivatives as PI3-kinases inhibitors | Boehringer Ingelheim Pharma GmbH & Co. KG (DE) | 2008-08-06 | — | — | EP | disclosed |